Buying or Selling a California Cannabis Business: A Practical Guide

Buying or selling a California cannabis business is fundamentally different from a typical small business transaction. The most important concept to understand at the outset: California cannabis licenses are not transferable. A cannabis license is issued to a specific licensee entity by the Department of Cannabis Control (DCC) and remains with that entity. There is no mechanism in California cannabis law to transfer a license from one entity to another.

This single fact drives nearly every structural decision in California cannabis M&A. Whether a transaction requires a new license application, triggers DCC ownership change pre-approval, qualifies for license continuity, or requires complete operational restart depends entirely on how the deal is structured.

This guide explains the structural reality of California cannabis M&A: why licenses don’t transfer, how different deal structures handle the non-transferability, when new license applications are required, when ownership change pre-approval applies instead, and how to plan due diligence and timelines accordingly.

The Core Concept: California Cannabis Licenses Don’t Transfer

California cannabis regulations issue licenses to specific licensee entities. The license is bound to that entity. When the entity ceases to exist, the license ends. When the entity is sold, the license remains with the entity (now under new ownership), but it cannot be moved to a different entity.

This has critical implications:

• You cannot buy a cannabis “license” as a standalone asset. A license cannot be carved out of an entity and sold separately.
• You cannot transfer a license from Entity A to Entity B. Even if both entities are owned by the same people, the license stays with the entity it was issued to.
• Asset purchases of a cannabis business do not transfer the license. The buyer must obtain new licenses to operate.
• Equity purchases of a licensed entity preserve the license, because the entity (and therefore the license) continues to exist with new owners.

These rules govern both DCC state licenses and local cannabis permits. Local cannabis permits in California are similarly non-transferable: City of Sacramento Cannabis Business Operating Permits, Los Angeles cannabis permits, San Francisco cannabis permits, and so on are all tied to specific permittee entities.

The buyer’s choice of deal structure therefore determines whether the buyer can rely on existing licenses or must apply for new ones — and that determines transaction timeline, cost, risk, and feasibility.

Deal Structure Options and Their License Implications

California cannabis M&A typically uses one of three structural approaches, each with fundamentally different license implications.

Asset Purchase Agreement (APA): No License Continuity

In an APA, the buyer purchases specific assets — equipment, inventory, intellectual property, real estate, customer lists — without acquiring the seller’s entity. The seller’s entity continues to exist (or winds down separately) and retains its cannabis license.

License consequences:

• Buyer does not receive any cannabis license through the APA itself
• Buyer must apply for new DCC licenses for each operation it intends to conduct
• Buyer must apply for new local cannabis permits in each jurisdiction
• Buyer cannot operate as a cannabis business until new licenses are issued

Practical timeline if using APA:

• APA closing on assets: typical 30-90 day timeline once due diligence is complete
• New DCC license application: typically 6-12 months from submission, sometimes longer
• New local cannabis permit application: 6 months to 2+ years depending on jurisdiction (capped jurisdictions may have no path to new licensure at all)
• Total timeline from APA closing to legal cannabis operations: 1-3 years

In capped jurisdictions where new licenses aren’t being issued, APA closing may leave the buyer with assets but no path to ever obtain a license. The APA assets become useful only if the buyer can find a way to attach them to a separately-licensed entity.

When APA makes sense for California cannabis:

• Acquiring brand or IP without the operating business (separate IP entity holds the brand; license-holding operating company doesn’t transfer)
• Acquiring real estate without the licensed operator (real estate holding company, not the operator)
• Wind-down transactions where the seller’s license is being voluntarily surrendered
• Unwind transactions between affiliated parties
• Affiliate restructurings where the buyer already has its own licenses and wants specific assets from another affiliate
• Distressed asset purchases where the seller’s entity has lost its license through enforcement action and the assets are being liquidated

For most California cannabis transactions where the license is the primary value driver, APA is not viable.

Membership Interest Purchase Agreement (MIPA) or Stock Purchase Agreement (SPA): License Continuity Through Entity Continuity

In a MIPA (for LLCs) or SPA (for corporations), the buyer purchases the equity interests of the entity that holds the cannabis license. The licensed entity itself continues to exist with the same DCC license, the same local cannabis permits, and the same operational identity. Only the ownership of the entity changes.

License consequences:

• Buyer may be able to operate as a cannabis business through the acquired entity immediately upon closing (subject to ownership change disclosures, discussed below)
• Customer relationships, supply contracts, METRC integration, and operational history continue
• Ownership change notifications are required before closing — the entity continues, but its ownership change must be pre-approved by the DCC and local jurisdictions
• Buyer may inherit entity liabilities (regulatory, tax, employment, contractual)

Practical timeline:

• Due diligence and negotiation: 60-180 days
• DCC ownership change pre-approval: typically 60-120 days from complete submission
• Local jurisdiction pre-approval: typically 30-180 days, varies by jurisdiction
• Closing after regulatory approvals: typically 30-60 days
• Total typical timeline from LOI to closing: 6-12 months

Hybrid and Multi-Step Structures

Sophisticated California cannabis transactions sometimes use hybrid structures that combine elements of asset and equity transactions:

Asset drop-down with equity sale:

• Seller drops desired assets into a new subsidiary entity
• That subsidiary then transfers (with assets) to the buyer through equity purchase
• The original parent entity (which held the license) either continues separately or winds down
• License consequence: the new subsidiary does NOT inherit the original entity’s cannabis license. If the new subsidiary needs a cannabis license, it must apply for one.

This structure is rarely used for the operating business itself because of the license problem, but it’s sometimes used for ancillary assets (IP, real estate, brand) where the buyer doesn’t need a license.

Reverse triangular merger:

• Buyer creates a subsidiary
• The subsidiary merges into the licensed target entity
• The target entity survives the merger
• The target entity becomes a wholly-owned subsidiary of the buyer

Reverse triangular merger preserves license continuity because the licensed entity survives the transaction. It’s effectively similar to an equity purchase but accomplished through merger mechanics. Tax and structural considerations sometimes favor this structure for sophisticated transactions.

Two-step structures:

• Initial minority equity investment (typically below DCC pre-approval thresholds)
• Call option to acquire control over time, exercised after specific milestones
• Eventual full equity purchase triggers ownership change pre-approval at that point

Two-step structures spread regulatory risk over time and let buyers conduct extended operational due diligence before committing to control. They’re particularly useful for first-time California cannabis investors.

Holding company structures:

• Existing licensed operating entity remains intact
• Buyer’s holding company acquires equity in the operating entity
• Holding company structure provides liability separation and consolidation flexibility
• License continuity is preserved at the operating entity level

This structure is common for multi-state operators and institutional investors entering California cannabis.

For most California cannabis transactions, a straightforward MIPA or SPA is sufficient. Hybrid structures are typically reserved for larger transactions, multi-state operators with complex tax planning, or situations where standard equity purchase doesn’t accomplish all transaction objectives.

Due Diligence Priorities

California cannabis business due diligence covers standard M&A topics plus cannabis-specific items. Given the license non-transferability framework, certain due diligence priorities are particularly important.

License and Regulatory Status

• Current DCC license status, type, and renewal history
• All current local cannabis permits and conditions of approval in every jurisdiction the entity operates
• License expiration dates and renewal status (a license expiring during the regulatory pre-approval period creates serious complications)
• All pending regulatory matters: Notices to Comply, Accusations, disciplinary proceedings
• DCC enforcement history including any prior settlements or sanctions
• METRC reporting accuracy and any track-and-trace discrepancies (frequent source of post-closing problems)
• Local tax compliance status (cannabis business operations taxes vary by jurisdiction)
• State tax compliance: CDTFA cannabis excise tax, sales and use tax
• Federal tax compliance under § 280E

License status verification is particularly critical. A buyer paying premium for an entity’s “license” is paying for an asset that doesn’t legally transfer — the value is in the entity’s continued ability to use that license. If the license is expiring soon, in active enforcement, or otherwise impaired, the value the buyer thought it was acquiring may not exist.

Ownership and Disclosure Verification

• Verification that all current owners and financial interest holders match DCC and local filings
• Identification of any undisclosed beneficial owners (a frequent source of post-closing regulatory exposure)
• Review of all operating agreements, shareholder agreements, voting agreements
• Buyout, transfer restriction, and right of first refusal provisions affecting the sale
• Pending ownership disputes among current owners
• Source of funds for current ownership stakes

Undisclosed beneficial ownership in the seller’s entity creates regulatory exposure for the buyer post-closing. The DCC’s pre-approval of new ownership is based on disclosed information. If the buyer later discovers undisclosed beneficial owners that should have been disclosed historically, the entity faces enforcement risk regardless of when the undisclosed ownership originated.

Financial and Tax

• Three years of financial statements (or as many as the business has)
• Three years of tax returns including 280E treatment review
• Cannabis-specific tax planning analysis (Schedule III rescheduling implications)
• METRC inventory reconciliation against accounting records
• Cash position, accounts receivable aging, and accounts payable status
• Outstanding loans, convertible notes, royalty obligations, and other financial obligations
• Any tax liens or pending tax disputes

Operational

• Premises lease or ownership documentation, including any cannabis-specific lease provisions
• Verification that the premises matches the premises diagram on file with the DCC and local jurisdiction (premises modifications without prior approval can affect license status)
• All operational SOPs, training records, and compliance documentation
• Security infrastructure: cameras, alarms, storage, transport
• Inventory and METRC track-and-trace records, with reconciliation against physical inventory
• Customer relationships and supply contracts (especially for distribution and manufacturing)
• Employee compensation, benefits, and any pending employment matters
• Insurance coverage adequacy across general liability, product liability, and cannabis-specific policies

Litigation and Liability

• All pending or threatened litigation
• Past customer complaints and product liability matters
• Employment claims (wage and hour, harassment, discrimination, retaliation)
• Environmental compliance matters (especially for cultivation operations under CEQA and water regulations)
• Workers’ compensation history and pending claims
• Any pending criminal investigations of the entity or its owners

In equity-purchase structures, the buyer inherits all entity-level liabilities. Pre-closing employment claims, tax violations, regulatory issues, and contractual disputes become buyer’s responsibility post-closing. Indemnification provisions in the MIPA can shift some risk back to seller, but practical recovery depends on indemnification escrows or seller solvency.

Cannabis-Specific Risk Areas

• 280E exposure and tax planning history
• Federal banking limitations affecting transaction mechanics
• Federal illegality risk allocation in transaction documents
• Schedule III rescheduling implications for entity structure and tax treatment
• METRC reporting integrity (a high-stakes area where buyers should commission their own audit)
• Marketing and advertising compliance history (particularly for retailers and brand-driven operators)
• Trade samples compliance history (a frequent source of DCC enforcement actions)
• Recall history and current product safety position
• Pesticide application records (for cultivators)
• Water rights compliance (for cultivators using surface or groundwater)

Pricing and Valuation Considerations

California cannabis businesses are typically valued using a combination of methodologies:

• Revenue and EBITDA multiples — typical multiples vary by license type, jurisdiction, and operational maturity
• License value (entity value, more accurately) — particularly for capped local jurisdictions where the license-holding entity has scarcity value beyond operational metrics
• Real estate value — if the business owns property suitable for continued cannabis operations
• Customer relationships and supply contracts — especially for distribution and manufacturing
• Brand and IP value — for businesses with established consumer brands
• Operational infrastructure value — security systems, METRC integration, SOPs, trained staff

The non-transferability of licenses affects valuation. The premium that buyers pay for an entity above asset-replacement value is the premium for the entity’s license-holding status combined with operational continuity. APA transactions cannot capture this premium because the buyer doesn’t acquire the license-holding entity.

California cannabis business valuations are typically depressed compared to non-cannabis businesses with similar financial metrics, due to:

• 280E tax burden reducing effective profitability and free cash flow
• Federal illegality limiting buyer pool (no public capital markets, limited institutional investors)
• Cannabis banking limitations affecting transaction mechanics and ongoing operations
• Regulatory complexity reducing buyer confidence
• Market oversupply in some segments (particularly cultivation) depressing operating margins

Schedule III rescheduling, depending on how it ultimately affects 280E tax treatment and federal banking access, may improve cannabis business valuations over the next 12-24 months.

License-Specific Valuation Considerations

Different California cannabis license types command different valuation premiums:

• Storefront retail dispensaries in capped jurisdictions command the highest valuations relative to underlying financials due to license-holding entity scarcity
• Type 7 volatile manufacturing entities (BHO/extraction) command premiums due to scarcity and operational complexity barriers
• Established distributors with customer relationships command premiums due to relationship-driven revenue
• Microbusinesses with multi-license capability command premiums for operational flexibility
• Cultivation entities in the current oversupply environment generally command lower multiples; outdoor and small-scale operations are particularly affected

Earnouts and Contingent Consideration

Many California cannabis transactions include earnouts or contingent consideration tied to post-closing performance. Common structures:

• Revenue-based earnouts — additional consideration paid based on post-closing revenue achievement
• EBITDA-based earnouts — paid based on post-closing operating performance
• Regulatory milestone earnouts — paid upon successful license renewal, premises modifications, or specific regulatory achievements
• Customer retention earnouts — particularly for distribution operations
• Hybrid earnouts — combining multiple performance metrics

Earnouts can bridge valuation gaps between buyers and sellers but add complexity. Earnout structures must specify measurement methodology, period duration, operational covenants protecting earnout potential, and dispute resolution mechanics.

Tax and Structuring Considerations

California cannabis transactions involve several tax-specific considerations.

Section 280E

Section 280E disallows ordinary business deductions for cannabis businesses, dramatically increasing effective tax burden. Both buyer and seller need to model 280E impact:

• Seller’s perspective: capital gains treatment on the sale itself versus ordinary income from continued operations under 280E. The tax difference between holding and selling can be significant.
• Buyer’s perspective: post-closing 280E exposure reduces effective return on acquisition price. Acquisition models should reflect 280E-impacted cash flows.

Schedule III rescheduling may modify 280E treatment for cannabis businesses with federal DEA registration under 21 C.F.R. § 1301.13(k). Sellers may benefit from delaying transactions until 280E is resolved; buyers may benefit from acting before market expectations adjust to favorable 280E changes.

Tax Basis Considerations

In equity purchases (MIPA/SPA), the buyer typically does not get a step-up in tax basis on the entity’s underlying assets. The entity’s existing tax basis carries over. For cannabis businesses with substantial intangible assets (license value, brand value, customer relationships), this creates a meaningful tax disadvantage compared to asset purchases — but as discussed above, asset purchases typically don’t work for cannabis license-driven transactions.

A 338(h)(10) election can sometimes provide step-up benefits in equity purchases of S corporations or certain other entity structures. This election should be considered in tax planning, with the understanding that not all cannabis entity structures qualify.

Federal Banking and Payment

Cannabis businesses face limited banking options. M&A transactions involving large dollar amounts must accommodate:

• Limited buyer access to traditional debt financing (most cannabis acquisitions are equity-funded or seller-financed)
• Wire transfer restrictions at some institutions
• Cash transaction documentation requirements for AML/BSA compliance
• Escrow arrangements at cannabis-friendly institutions
• Multi-stage payment structures to manage banking constraints

Most California cannabis M&A transactions structure payments through cannabis-friendly banks, escrow arrangements, seller financing, or hybrid combinations.

Entity Structure Decisions Post-Closing

Buyers often restructure cannabis acquisitions for tax and liability optimization post-closing. However, restructuring of the licensed entity itself is constrained by license non-transferability. Restructuring options include:

• Holding company structure — placing a HoldCo over the operating entity (the licensed entity remains intact, with a new parent above it)
• IP separation — moving trademarks and brand IP to a separate non-licensed entity for protection across the federal-state framework
• Real estate separation — placing property in a PropCo for separation of operating and real estate risk
• EmployeeCo structure — separating employment functions for 280E mitigation strategies

Importantly: the licensed operating entity itself cannot be restructured in ways that change its fundamental identity without affecting the license. Mergers, conversions, and similar entity changes may trigger DCC pre-approval requirements or, in some cases, may invalidate the license. Counsel should review any post-closing restructuring against current DCC requirements before implementation.

Multi-State and Complex Transactions

California cannabis transactions involving multi-state operators (MSOs) or complex corporate structures add additional considerations:

Multi-State Operator Acquisitions

Buyers acquiring MSOs with California operations face:

• Parallel pre-approvals in California (DCC and local) and other states (state cannabis regulators and local jurisdictions)
• Each state’s cannabis licenses are non-transferable and follow that state’s specific licensee entity
• Coordination of timing across multiple regulatory tracks
• Allocation of purchase price across state-specific entities and assets
• Tax planning across multiple state cannabis frameworks
• Insurance coverage coordination across multiple jurisdictions
• Brand and IP allocation if the MSO operates under unified branding

Private Equity and Institutional Buyers

Private equity funds and institutional buyers entering California cannabis face:

• Additional ownership disclosure scrutiny (DCC examines fund structures, LP interests, and beneficial ownership)
• Regulatory review of fund structure and decision-making authority
• Investment committee approval requirements interacting with regulatory timing
• Reporting obligations to limited partners and investors
• Exit planning constraints under cannabis regulations

Foreign and Out-of-State Buyers

Buyers based outside California face:

• Additional disclosure requirements for foreign nationals (where applicable)
• Tax structuring considerations for non-California residents
• Practical considerations for managing California operations from outside the state
• Engagement of California-based operational management (often required by local cannabis ordinances)

Post-Closing Transition

California cannabis transactions typically involve a structured post-closing transition. Because the licensed entity continues uninterrupted in MIPA structures, transition planning focuses on operational continuity rather than license transfer:

• Operational handover — seller-buyer transition of operational knowledge, including customer relationships, supplier relationships, regulatory contacts, and operational nuances
• METRC user transitions — adding buyer personnel to METRC and removing seller personnel; coordination with state and local METRC requirements
• DCC notification of closing — confirming the regulatory ownership change and any subsequent corporate actions
• Local jurisdiction notifications — confirming closing with local cannabis offices
• Insurance transitions — buyer assuming or replacing insurance coverage with no gaps
• Employee transitions — assuming, replacing, or restructuring the workforce
• Banking transitions — moving operating accounts to buyer-controlled banking, often complicated by cannabis banking limitations
• Customer and supplier introductions — particularly important for distribution and manufacturing operations
• Brand transitions — if the brand changes hands or rebranding occurs

A well-structured transition agreement specifies who does what during the transition period, what compensation flows during transition, and what milestones mark transition completion. Transition periods typically last 30-180 days depending on transaction complexity.

Common California Cannabis M&A Pitfalls

Frequent failure modes:

• Misunderstanding license transferability — buyers and sellers structuring deals as license transfers and discovering the structural mismatch late in the process
• APA structures for cannabis assets — using asset-purchase structure expecting to receive licenses, then discovering new applications are required
• Pre-LOI conduct creating disclosure obligations — informal discussions or shared information may trigger DCC disclosure obligations before deal terms are firm
• Inadequate ownership diligence — undisclosed beneficial owners discovered post-closing create regulatory exposure for the buyer
• Skipping or rushing regulatory pre-approvals — closings before DCC and local approval expose buyer to operational disruption and regulatory enforcement
• Inadequate METRC reconciliation — track-and-trace discrepancies discovered post-closing become buyer’s problem and can trigger DCC enforcement
• Inadequate 280E modeling — buyers underestimating tax burden discover transaction economics don’t work as projected
• Earnout disputes — poorly drafted earnout provisions become the source of post-closing litigation
• Insurance gaps during transition — coverage gaps between seller’s policy lapse and buyer’s policy effective date create catastrophic exposure
• Employment claims surfacing post-closing — pre-closing wage and hour violations become buyer’s liability under successor liability principles
• Premises lease default during transition — landlord consent or estoppel issues that surface late in the process
• Cannabis banking failures during transition — banking relationships that don’t transfer as expected
• Pesticide and water rights non-compliance — cultivator-specific issues that don’t surface in standard due diligence
• Trademark and brand disputes — federal trademark issues affecting cannabis branding

The first pitfall is the most fundamental: misunderstanding the basic structural rule that cannabis licenses don’t transfer. Every other pitfall on this list is downstream of having a proper transaction structure in place from the beginning.

When to Engage Cannabis Counsel

Both buyers and sellers benefit from engaging cannabis counsel early in the transaction process.

For sellers:

• Before any informal discussions with potential buyers (informal sharing can trigger disclosure obligations)
• Before signing any LOI
• Before disclosing financial information or operational details
• Before negotiating any earnout or contingent consideration structure
• Before responding to unsolicited inquiries from potential acquirers

For buyers:

• Before submitting any LOI
• Before engaging in serious due diligence
• Before agreeing to any deal structure (the first decision — equity vs. asset — drives everything else)
• Before signing any NDA that may affect deal flexibility
• Before committing to financing or capital structure decisions

Counsel engaged at the pre-LOI stage can structure the transaction to optimize for tax, regulatory, and risk considerations — including ensuring the chosen structure actually accomplishes the transaction objectives given the license non-transferability constraint. Counsel engaged after LOI signing has fewer options to optimize structure and may need to renegotiate terms that were committed too early.

Sacramento and Other Local Markets

California cannabis M&A activity varies substantially by jurisdiction. Markets with limited license availability and capped retail (like the City of Sacramento) generate substantial secondary market activity, because new entrants must acquire existing licensee entities. Markets with abundant license availability generate less M&A and more fresh applications.

For operators considering acquisition or sale of a cannabis business in a specific California jurisdiction, local market dynamics significantly affect transaction structure, valuation, and timing. For Sacramento-specific transaction guidance, see our Sacramento Cannabis Business Acquisition and Sale Guide.

Schedule III Rescheduling Considerations

The April 2026 Schedule III rescheduling of FDA-approved marijuana products and state-licensed medical operations creates new considerations for California cannabis M&A:

• 280E treatment may change for medical operators with federal DEA registration under 21 C.F.R. § 1301.13(k)
• Federal banking access may improve for Schedule III-registered operators
• Acquisition financing may become more accessible as banks and lenders adjust to Schedule III status
• Valuations may shift as market expectations adjust to evolving federal treatment

Buyers and sellers should account for these evolving dynamics in transaction planning. Federal DEA registration status is increasingly relevant to California cannabis M&A valuations and structures. For more on federal registration, see our Federal Cannabis Attorney and DEA Registration practice pages.

---

Kocot Law handles California cannabis business acquisitions and sales → for buyers and sellers across all license types and jurisdictions. Practice includes MIPA, SPA, and asset-purchase structures, DCC ownership change pre-approval coordination under § 15003 and § 15004, local jurisdiction pre-approvals, due diligence support, transaction structuring, and post-closing transition. The firm is licensed in California, New York, and Massachusetts. Contact us to discuss your California cannabis transaction.